One of the well-known oncogenic alterations of the mTOR pathway is the RICTOR amplification, which has been shown to contribute to progression and metastasis in certain cancers through its association with the molecular signaling behind these processes (e.g., Wnt/β-katenin, MAPK/ERK pathways) [41]. This evidence concerns the gene RICTOR and cancer.